Alexander P J Vlaar Selected Research

Transfusion-Related Acute Lung Injury

1/2022	Reported transfusion-related acute lung injury associated with solvent/detergent plasma - A case series.
12/2020	Transfusion in the mechanically ventilated patient.
10/2019	The Role of Complement in Transfusion-Related Acute Lung Injury.
1/2019	A consensus redefinition of transfusion-related acute lung injury.
1/2019	Transfusion-associated circulatory overload-a systematic review of diagnostic biomarkers.
1/2016	Redefining transfusion-related acute lung injury: don't throw the baby out with the bathwater.
9/2015	Antibody-mediated transfusion-related acute lung injury; from discovery to prevention.
1/2015	Pathogenesis of non-antibody mediated transfusion-related acute lung injury from bench to bedside.
1/2013	[Transfusion-related acute lung injury].
10/2012	Transfusion-related acute lung injury in cardiac surgery patients is characterized by pulmonary inflammation and coagulopathy: a prospective nested case-control study.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alexander P J Vlaar Research Topics

Disease

21	COVID-19 10/2022 - 01/2020
17	Transfusion-Related Acute Lung Injury 01/2022 - 02/2010
16	Critical Illness (Critically Ill) 09/2022 - 06/2012
13	Inflammation (Inflammations) 01/2022 - 01/2011
10	Sepsis (Septicemia) 01/2022 - 03/2010
9	Hemorrhage 05/2022 - 10/2017
9	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2022 - 08/2012
7	Heart Arrest (Cardiac Arrest) 07/2022 - 01/2019
7	Infections 01/2022 - 07/2012
7	Lung Injury 01/2013 - 10/2007
7	Ventilator-Induced Lung Injury 01/2013 - 01/2009
6	Acute Lung Injury 10/2019 - 03/2010
5	Pneumonia (Pneumonitis) 01/2022 - 01/2012
5	Pulmonary Edema 01/2019 - 01/2009
4	Shock 12/2020 - 01/2009
4	Endotoxemia 11/2017 - 01/2016
3	Venous Thrombosis (Deep-Vein Thrombosis) 09/2022 - 01/2017
3	Out-of-Hospital Cardiac Arrest 07/2022 - 01/2019
3	Wounds and Injuries (Trauma) 01/2022 - 01/2011
3	Pulmonary Embolism 01/2022 - 01/2021
3	Thrombocytopenia (Thrombopenia) 01/2022 - 01/2016
3	Respiratory Insufficiency (Respiratory Failure) 08/2021 - 01/2018
3	ST Elevation Myocardial Infarction 01/2021 - 04/2019
3	Heart Failure 12/2020 - 01/2018
3	Body Weight (Weight, Body) 10/2020 - 11/2017
2	Venous Thromboembolism 01/2022 - 12/2020
2	Transfusion Reaction 01/2022 - 01/2019
2	Thrombosis (Thrombus) 01/2021 - 01/2021
2	Dyspnea (Shortness of Breath) 12/2020 - 01/2019
2	Acute Kidney Injury (Acute Renal Failure) 10/2020 - 04/2019
2	Hypoxia (Hypoxemia) 10/2020 - 05/2018
2	Ventricular Tachycardia 04/2019 - 01/2019
2	Hematologic Neoplasms (Hematological Malignancy) 01/2019 - 03/2010
1	Ischemic Stroke 05/2022
1	Hypotension (Low Blood Pressure) 01/2022
1	Cytokine Release Syndrome 01/2022
1	Thrombophilia 01/2022
1	Pancreatitis 01/2022
1	Thromboinflammation 05/2021
1	Clinical Deterioration 05/2021
1	Disease Progression 05/2021
1	Acute-Phase Reaction 01/2021

Drug/Important Bio-Agent (IBA)

11	AntibodiesIBA 01/2022 - 10/2007
9	LipopolysaccharidesIBA 01/2018 - 07/2010
8	CytokinesIBA 01/2022 - 01/2009
7	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2011
7	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2009
5	Complement System Proteins (Complement)IBA 05/2021 - 10/2019
4	LipidsIBA 01/2012 - 10/2007
3	Heparin (Liquaemin)FDA LinkGeneric 05/2022 - 08/2012
3	Interleukin-6 (Interleukin 6)IBA 01/2022 - 01/2011
3	AntigensIBA 09/2015 - 10/2010
2	vilobelimabIBA 01/2022 - 12/2020
2	BNT162 VaccineIBA 01/2022 - 10/2021
2	AnaphylatoxinsIBA 01/2022 - 12/2020
2	Monoclonal AntibodiesIBA 01/2022 - 12/2020
2	EnzymesIBA 01/2022 - 11/2017
2	Hemoglobins (Hemoglobin)IBA 01/2022 - 01/2017
2	InterleukinsIBA 01/2022 - 05/2021
2	Tranexamic Acid (AMCA)FDA Link 01/2022 - 12/2021
2	Messenger RNA (mRNA)IBA 10/2021 - 01/2017
2	Immunoglobulin G (IgG)IBA 01/2021 - 01/2021
2	Toll-Like Receptor 4IBA 01/2013 - 01/2012
2	Plasminogen Activators (Plasminogen Activator)IBA 10/2012 - 01/2011
2	AntithrombinsIBA 10/2012 - 01/2011
2	Thrombin FDA Link 10/2012 - 01/2011
2	InflammasomesIBA 05/2012 - 01/2012
1	Detergents (Detergent)IBA 01/2022
1	Lipoprotein(a)IBA 01/2022
1	Furosemide (Lasix)FDA LinkGeneric 01/2022
1	mRNA VaccinesIBA 01/2022
1	Immunomodulating AgentsIBA 01/2022
1	Neutralizing AntibodiesIBA 01/2022
1	VaccinesIBA 01/2022
1	C-Reactive ProteinIBA 01/2022
1	SteroidsIBA 01/2022
1	SolventsIBA 01/2022
1	Gonadal Steroid Hormones (Sex Hormones)IBA 08/2021
1	Testosterone (Sustanon)FDA Link 08/2021
1	Erythropoietin FDA Link 01/2021

Therapy/Procedure

11	Artificial Respiration (Mechanical Ventilation) 10/2022 - 01/2009
11	Blood Transfusion (Blood Transfusions) 05/2022 - 08/2009
11	Therapeutics 01/2022 - 06/2012
9	Extracorporeal Membrane Oxygenation 09/2022 - 01/2018
6	Mechanical Ventilators (Ventilator) 10/2020 - 01/2009
5	Critical Care (Surgical Intensive Care) 12/2021 - 02/2010
4	Length of Stay 10/2020 - 03/2010
3	Platelet Transfusion (Blood Platelet Transfusions) 01/2022 - 07/2012
3	Central Venous Catheters 01/2022 - 10/2017
3	Positive-Pressure Respiration (Positive End-Expiratory Pressure) 09/2021 - 05/2018
3	Percutaneous Coronary Intervention 01/2021 - 04/2019
2	Erythrocyte Transfusion 08/2022 - 12/2020
2	Resuscitation 07/2022 - 10/2020
2	Immunotherapy 01/2022 - 01/2022
2	Catheters 01/2021 - 01/2021
1	Cannula 09/2022
1	General Anesthesia 01/2022
1	Induced Hypothermia 01/2022
1	Hormone Replacement Therapy (Therapy, Hormone Replacement) 08/2021
1	Embolectomy 01/2021